【制药网 行业动态】在医药行业的发展进程中,合作与联盟一直是推动创新药物研发与商业化的重要力量。与此同时,药企之间合作终止也是常态。进入2025年,药企终止合作的消息密集,近期就涉及罗氏、默沙东、艾迪药业等国内外企业。近日,罗氏旗下的基因泰克宣布将终止与BicycleTherapeutics的合作协议,该决定将于8月正式生效。回溯至2020年2月,基因泰克与Bicycle建立了独家合作关系,彼时...
Source Link【制药网 行业动态】在医药行业的发展进程中,合作与联盟一直是推动创新药物研发与商业化的重要力量。与此同时,药企之间合作终止也是常态。进入2025年,药企终止合作的消息密集,近期就涉及罗氏、默沙东、艾迪药业等国内外企业。近日,罗氏旗下的基因泰克宣布将终止与BicycleTherapeutics的合作协议,该决定将于8月正式生效。回溯至2020年2月,基因泰克与Bicycle建立了独家合作关系,彼时...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.